Joshua Hill, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Allovir
    Topic:
    Transplant ID expertise
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Century Therapeutics
    Topic:
    CAR-T cell therapy and infections
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    10/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    CSL Behring
    Topic:
    CAR-T cell therapy and infections
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Eversana
    Topic:
    Delphi panel for SARS-CoV-2 testing in immunocompromised patients
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    02/28/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    GeoVax
    Topic:
    ID protocol development
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Gilead
    Topic:
    ID protocol development
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    11/15/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Gilead
    Topic:
    CAR-T cell therapy and infections
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Grifols
    Topic:
    CAR-T cell therapy and infections
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Karius
    Topic:
    ID diagnostics
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Moderna
    Topic:
    Vaccine trail DSMB
    Date added:
    05/07/2024
    Date updated:
    05/07/2024
    Relationship end date:
    01/05/2024

Pages

Return to 2024 Seattle Cellular Therapy Summit: Updates and Focus on Accessibility